Renasant Bio

📍 Berkeley, United States👥 25 employees💰 Last funded Jun 2022
Biotechnology Research🌐 renasantbio.com
Website LinkedIn
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of end-stage renal failure. Renasant is advancing a pipeline of oral small molecule corrector and potentiator programs that target the underlying biology of ADPKD to restore the function of key proteins to halt disease progression.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Renasant Bio?
Renasant Bio has 1 investors on record on gritt.io.
When did Renasant Bio last raise funding?
The most recent investment in Renasant Bio recorded on gritt.io was in June 2022.
What industry is Renasant Bio in?
Renasant Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Renasant Bio based?
Renasant Bio is headquartered in Berkeley, United States.